Figure 7 showed the activation of the inflammasome downstream molecules in rats with AD, depicted by the bolstered hippocampal content of (a) cleaved caspase-1 (2.6 fold), (b) IL-1β (5.6 fold), (c) IL-18 (4.9 fold), and the non-canonical marker (d) caspase-11 (3.8 fold), as compared to the normal group. The gene discussed is CASP1; the disease is Alzheimer disease.